Formulations:
- Parenteral > General injections > IV: 10 mg per mL concentrate solution for infusion
Parenteral > General injections > IV: 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion; 10 mg per mL in 24 mL vial concentrate solution for infusion
Parenteral > General injections > IV: 10 mg per mL in 24 mL vial concentrate solution for infusion; 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion
Indications:
- Other specified malignant neoplasms of bronchus or lung
- Melanoma of skin
- Renal cell carcinoma of kidney, except renal pelvis
- Squamous cell carcinoma of oesophagus
- Adenocarcinoma of oesophagogastric junction
- Adenocarcinoma of stomach
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 10 mg per mL concentrate solution for infusion
Parenteral > General injections > IV: 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion; 10 mg per mL in 24 mL vial concentrate solution for infusion
Parenteral > General injections > IV: 10 mg per mL in 24 mL vial concentrate solution for infusion; 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion
Indications:
- Other specified malignant neoplasms of bronchus or lung
- Melanoma of skin
- Renal cell carcinoma of kidney, except renal pelvis
- Squamous cell carcinoma of oesophagus
- Adenocarcinoma of oesophagogastric junction
- Adenocarcinoma of stomach
Source: EML workbook import